Humans have a remarkable ability to snap back from traumatic events, but the COVID-19 pandemic is pushing the limits of human resilience—and researchers’ understanding of it.

A COVID-19 survivor in her 20s received a double lung transplant last week after being on a ventilator and heart-lung machine for nearly 2 months, AP reports.   The procedure is believed to be the first of its kind in the US.  

Blood clots. Purple toes. Kidney damage. Heart inflammation.   While COVID-19 is widely known as a respiratory illness, its roster of mysterious symptoms is pointing researchers to a surprising possibility—what if COVID-19 only begins as a respiratory infection, but…

The COVID-19 pandemic has put the opioid crisis on the back burner of news cycles—and it's made the crisis harder to fight, National Geographic reports.

Police are brutally enforcing lockdowns and curfews in several African countries, Deutsche Welle reports. The approach could backfire and lead to unrest that countries can ill afford while they're trying to fight COVID-19, human rights groups warn.

Another COVID-19 target: The lining of blood vessels, which can lead to multiple organ failures seen in many patients.   Findings from a new Lancet study may help explain why smokers, who have less healthy blood vessels, have been more vulnerable to the virus. The study …

Clinicians are charting gruesome carnage in COVID-19 patients that extends far beyond the lungs, according to The Washington Post. Damage includes:  

COVID-19 appears to kill more men than women in many hard-hit countries—mystifying experts.

A new, 6-month treatment has cured 90% of people with stubborn drug-resistant tuberculosis—who typically face limited treatment options and poor outcomes, according to clinical trial results published today in The New England Journal of Medicine.

Last year, it looked like 2 million babies would go without the crucial vaccine for rotavirus, a disease that causes severe diarrhea and dehydration and kills 200,000 children and babies every year. After 6 years, Merck & Co scrapped a deal to supply RotaTeq vaccines…